MedPath

Early detection of breast cancer in women with a familial or genetic predisposition of developing breast cancer using biomarkers in serum

Recruiting
Conditions
Breast cancer, hereditary breast cancer
Registration Number
NL-OMON26238
Lead Sponsor
Genootschap Landgoed Keukenhof, A Sisters Hope, Pink Ribbon, Zabawas, Nuts-Ohra
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
1250
Inclusion Criteria

Women
- 25-75 years old
- Screening indication due to familiar or genetically enhanced risk of developing breast cancer or LTR > 15%

Exclusion Criteria

- Previous invasive breast cancer in medical history
- Other malignancies within the last 10 years (other than basal cell carcinoma)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analyzing the differences in protein profiles between patients and controls and within patients over time. Moreover, establishing a panel of protein-based biomarkers for the early detection of breast cancer.
Secondary Outcome Measures
NameTimeMethod
<br>The prognostic value of the selected protein profiles as biomarkers (5-year survival, disease free period and distant mestastasis)
© Copyright 2025. All Rights Reserved by MedPath